Evidence map›Paper›PMID 26078857›Full record

ArticleEcology and evolution2015

Antibodies to Pseudogymnoascus destructans are not sufficient for protection against white-nose syndrome.

Joseph S Johnson, DeeAnn M Reeder, Thomas M Lilley, Gábor Á Czirják, Christian C Voigt, James W McMichael, Melissa B Meierhofer, Christopher W Seery, Shayne S Lumadue, Alexander J Altmann and 2 more

Open access · goldAbstract read
In one paragraph

Article in Ecology and evolution, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Ecology and impacts of white-nose syndrome on bats.Nature reviews. Microbiology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Energy conserving thermoregulatory patterns and lower disease severity in a bat resistant to the impacts of white-nose syndrome.Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2018
    Article
  14. Article
  15. Immune responses in hibernating little brown myotis (Proceedings. Biological sciences · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Joseph S JohnsonDepartment of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
DeeAnn M ReederDepartment of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
Thomas M LilleyDepartment of Biology, University of Turku Turku, Finland.
Gábor Á CzirjákLeibniz Institute for Zoo and Wildlife Research Berlin, Germany.
Christian C VoigtLeibniz Institute for Zoo and Wildlife Research Berlin, Germany.
James W McMichaelDepartment of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
Melissa B MeierhoferDepartment of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
Christopher W SeeryDepartment of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
Shayne S LumadueDepartment of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
Alexander J AltmannDepartment of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
Michael O ToroDepartment of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
Kenneth A FieldDepartment of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
Bucknell University · USLeibniz Institute for Zoo and Wildlife Research · DEUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

White-nose syndrome (WNS) is a fungal disease caused by Pseudogymnoascus destructans (Pd) that affects bats during hibernation. Although millions of bats have died from WNS in North America, mass mortality has not been observed among European bats infected by the fungus, leading to the suggestion that bats in Europe are immune. We tested the hypothesis that an antibody-mediated immune response can provide protection against WNS by quantifying antibodies reactive to Pd in blood samples from seven species of free-ranging bats in North America and two free-ranging species in Europe. We also quantified antibodies in blood samples from little brown myotis (Myotis lucifugus) that were part of a captive colony that we injected with live Pd spores mixed with adjuvant, as well as individuals surviving a captive Pd infection trial. Seroprevalence of antibodies against Pd, as well as antibody titers, was greater among little brown myotis than among four other species of cave-hibernating bats in North America, including species with markedly lower WNS mortality rates. Among little brown myotis, the greatest titers occurred in populations occupying regions with longer histories of WNS, where bats lacked secondary symptoms of WNS. We detected antibodies cross-reactive with Pd among little brown myotis naïve to the fungus. We observed high titers among captive little brown myotis injected with Pd. We did not detect antibodies against Pd in Pd-infected European bats during winter, and titers during the active season were lower than among little brown myotis. These results show that antibody-mediated immunity cannot explain survival of European bats infected with Pd and that little brown myotis respond differently to Pd than species with higher WNS survival rates. Although it appears that some species of bats in North America may be developing resistance to WNS, an antibody-mediated immune response does not provide an explanation for these remnant populations.

Indexed as

Antibody-mediated immunityantifungal immunityCorynorhinusdisease ecologyEptesicushibernationMyotisPerimyotiswildlife diseaseWNS

Identifiers

PMID26078857
PMCPMC4461422
OpenAlexW2097897215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.